We will now publish more news in English – and offer yet another newsletter

Starting next week, Life Science Sweden will begin offering a newsletter entirely in English.

Stayble får europeiskt patent för engångsbehandling mot diskbråck

Stayble Therapeutics är på väg att beviljas ett europeiskt patent för sin behandling av diskbråck.

Novo Nordisk sues compounding pharmacies in the US

Novo Nordisk is suing compounding pharmacies in Florida, USA, because the company claims to have found impurities in the active ingredient in the obesity drug Wegovy.

The Swedish Academy of Sciences: “We have too many researchers”

Sweden does not need more researchers, but it does need better ones. According to the Royal Swedish Academy of Sciences, funding should be distributed to favour excellence.

MVA:s CEO: “Our investments should improve people´s everyday lives”

Involuntary infertility and diabetes are two of the areas on the agenda of the Medicon Valley Alliance.

Marie Gårdmark: ”The situation is not satisfactory”

”The legislative tool-box is limited, but carrots in the form of longer exclusivity has already proven successful, this has for example increased registration o...

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Björn Arvidsson: Let's build on the positive momentum

Progress needs narratives and heroes, and more than ever, going into the new year feels like an opportunity for a fresh start.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

Ylva Trolle Lagerros: ”Vissa borde få läkemedel mot obesitas subventionerat”

Som ledande expert på obesitas har Ylva Trolle Lagerros synts mycket i media på sista tiden. I en intervju med Life Science Sweden talar hon om stigmat kring fe...

Bioarctic fälls för vd-uttalanden till journalist – efter anmälan från konkurrent

I ett vägledande utslag fälls alzheimerbolaget Bioarctic för uttalanden som bolagets vd gjorde till en ekonomijournalist i somras.

Anna Törner: Vem betalar för Rebecca Doe – och alla oss andra?

Det lätt att vänja sig vid tanken att vård och läkemedel är gratis, när det egentligen handlar om hur och vem som betalar. Det skriver Anna Törner i en krönika.

Pharma Outsourcing igång på Stockholm Waterfront

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

Investments worth 40 billion in the Öresund region – “A huge investment wave”

A new report reveals that medical companies in the Oresund region are investing like never before.

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

ARM-D – Vill du spara plats i din maskin?

Nya modulära regulatorn ARM-D ger ett ytterst kompakt montage för samtidig reglering av flera tryck.

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

Anna Törner: To kill your darlings

Förhoppningarna var höga när Anna Törner och hennes kollega startade en studie om ett kosttillskott som verkade vara overkligt bra. "Entusiastiskt drömde vi om ...

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Årets mest lästa krönikor och opinionsartiklar

Branschspaningar och reflektioner är och har alltid varit en viktig del av Life Science Swedens redaktionella innehåll. När 2021 nu snart är till ända har vi sa...

This is the future location of the new national innovation cluster

Mölndal and Goco Health Innovation City will be the site of a new national innovation cluster for advanced therapies. The business community and the Swedish gov...

Why the world renown researcher Marc Tessier-Lavigne resigns as Stanford´s president

In mid-summer, neuroscientist Marc Tessier-Lavigne announced his resignation as President of Stanford following allegations of manipulated study data. According...

Krönika: Collaboration across borders